Apex Therapeutics, Inc.

Indianapolis, IN Doing business as Apexian Pharmaceuticals, Inc.

UEI
V9F1G49CLG95
CAGE
539M8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
20 N Meridian St #801, Indianapolis, IN 46204, USA
Website
apextherapeutics.com
Founded
2023
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel therapeutic strategy for refractory and relapse childhood acute leukemia R43CA171344 National Institutes of Health $240,322
Redox protein APE1/REF-1 as a target for age-related macular degeneration (AMD) R41EY019784 National Institutes of Health $225,064

Quick answers

Is Apex Therapeutics, Inc. registered in SAM.gov?

Yes. Apex Therapeutics, Inc.'s SAM.gov registration is active through August 10, 2027.

What is Apex Therapeutics, Inc.'s most recent federal award?

Apex Therapeutics, Inc.'s most recent federal grant award is Novel therapeutic strategy for refractory and relapse childhood acute leukemia (R43CA171344), from National Institutes of Health, on July 1, 2013.

On GovTribe

See Apex Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login